LoginTag: Adequan
Dec 12, 2020
VIDEO: Supporting Healthy Joint Function with Adequan I.M.
Active horses need healthy cartilage to maintain joint function. In joints with degenerative joint disease, also known as osteoarthritis, the complex process of cartilage repair is unable to keep up with damage. This video from Adequan explains the process of cartilage breakdown and how Adequan can help reduce inflammation, restore joint lubrication, repair cartilage, and reverse the disease cycle.
Mar 27, 2019
Association News
American Regent Animal Health Increases Support for the New $60,000 Adequan® USEA® Advanced Final
The United States Eventing Association (USEA) is excited to announce the renewed corporate partnership with longtime sponsor Adequan® i.m. (polysulfated glycosaminoglycan) as “The Official Joint Therapy Treatment of the USEA.” American Regent Animal Health, manufacturer of Adequan®, has increased its support of the USEA to be able to offer unparalleled prize money in the Advanced division at the 2019 USEA American Eventing Championships (AEC).
Apr 16, 2018
Association News
Adequan Returns as the Official Joint Therapy Treatment of the USEA
The United States Eventing Association (USEA) would like to welcome back longtime sponsor Adequan® i.m. (polysulfated glycosaminoglycan) as “The Official Joint Therapy Treatment of the USEA”, Title Sponsor of the USEA Gold Cup Series and Contributing Level Sponsor of the USEA American Eventing Championships (AEC).
Dec 06, 2013
Convention
USEA Annual Meeting and Convention- Update from Allyn Mann and Adequan
Wondering what's been going on with the shortage of Adequan this year? Luitpold Pharmaceutical's Allyn Mann gives an update on what happened and when you can expect supplies to return to normal.
Sep 17, 2013
Sponsor
Adequan Is Once Again Available in Limited Quantities
Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® IM, Adequan® IA, and Adequan® Canine provides the following supply update:
Aug 06, 2013
Sponsor
Luitpold Pharmaceuticals, Inc. Provides Adequan® (polysulfated glycosaminoglycan) Supply Update
Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® IM, Adequan® IA, and Adequan® Canine provide the following supply interruption update:
Jul 03, 2013
Sponsor
Luitpold Pharmaceuticals, Inc. Provides Adequan® Supply Update
Shirley, NY (June 27, 2013) – Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® IM, Adequan® IA, and Adequan® Canine provide the following supply interruption update:
Oct 04, 2012
Advanced Final
Courageous Comet Retires as 2012 Adequan USEA Gold Cup Champion
Becky Holder rode Tom Holder’s Courageous Comet to three top finishes in the 2012 Adequan USEA Gold Cup Series garnering an impressive 625 points to become the keeper of the cup for 2012. The results contributing to Becky and the 16-year-old Thoroughbred’s (Comet Shine x Rosenelli) lead included their win at the Nutrena USEA American Eventing Championships, second place at the Richland Park CIC3*, and third place in The Fork Advanced B division.
